Tirzepatide is a groundbreaking therapeutic agent for individuals battling type 2 diabetes. As a dual stimulator, it targets both the glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide https://gerardcjem282348.thenerdsblog.com/46646821/tirzepatide-a-new-frontier-in-diabetes-treatment